evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
18116,GENE_SUMMARY,,IGF2 encodes a peptide hormone which activates mitogenic signaling pathways by binding receptor tyrosine kinases. IGF2 is frequently overexpressed in a variety of cancers.,,2017-03-01,,3481,IGF2,insulin like growth factor 2,True,ENST00000434045,NM_001127598.1,C11orf43,PP9974,GRDF,IGF-II,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18117,GENE_BACKGROUND,,"IGF2 encodes insulin-like growth factor 2, a peptide hormone which binds to receptor tyrosine kinases to activate downstream mitogenic signaling pathways (PMID: 24080445, 25704323). IGF2 binds to one of several receptor tyrosine kinases, including IGF1R and Ir-A, to initiate a cascade that activates mitogenic and metabolic signaling via the PI3K-AKT and MAPK pathways (PMID: 24080445). In most adult tissues IGF2 is imprinted, and thus its expression is restricted to the paternal allele only (PMID: 12637750). Aberrant IGF2 expression, in many cases due to loss of imprinting, is implicated in the development of several tumor types (e.g. breast, ovarian, and Wilms tumors) (PMID: 17686827, 24080445), as well as the progression of tumors to more aggressive disease (e.g. breast cancer, chronic myeloid leukemia) (PMID: 20089431, 9558368, 24080445). Loss-of-imprinting of IGF2 is causative for Beckwith-Wiedemann syndrome, which confers an increased risk of developing childhood tumors such as Wilmsâ€™ tumor and hepatoblastoma (PMID: 8968759, 12668598, 23620526). Overexpression of IGF2 is also the critical event in non-islet cell tumor hypoglycemia (PMID: 24616774, 24080445).",,2017-03-01,,3481,IGF2,insulin like growth factor 2,True,ENST00000434045,NM_001127598.1,C11orf43,PP9974,GRDF,IGF-II,False,17686827,Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.,Journal of the National Cancer Institute,2018-08-15T20:07:00,99,16,1270-3,Bjornsson HT et al,,,0001-08-15,,24616774,Non-islet cell tumor-induced hypoglycemia: a report of five cases and brief review of the literature.,"Endocrinology, diabetes &amp; metabolism case reports",2013,2013,,130046,Dutta P et al,doi: 10.1530/EDM-13-0046,,"Dutta P et al. Endocrinology, diabetes &amp; metabolism case reports. 2013;2013()130046.",,12637750,Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.,"Science (New York, N.Y.)",2018-03-14T20:03:00,299,5613,1753-5,Cui H et al,,,0001-03-14,,9558368,Loss of imprinting in disease progression in chronic myelogenous leukemia.,Blood,0001-05-01,91,9,3144-7,Randhawa GS et al,,,0001-05-01,,24080445,IGF2 and cancer.,Endocrine-related cancer,2017-12-01T20:13:00,20,6,R321-39,Livingstone C,doi: 10.1530/ERC-13-0231,,0001-12-01,,12668598,Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development.,Human molecular genetics,2018-04-01T20:03:00,12 Spec No 1,,R61-8,Weksberg R et al,,,0001-04-01,,8968759,Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway.,Human molecular genetics,0001-12-01,5,12,2027-32,Brown KW et al,,,0001-12-01,,20089431,Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.,Growth hormone &amp; IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,2018-04-01T20:10:00,20,2,162-70,Kalla Singh S et al,doi: 10.1016/j.ghir.2009.12.002,,0001-04-01,,25704323,IGF2 signaling and regulation in cancer.,Cytokine &amp; growth factor reviews,2018-06-01T20:15:00,26,3,371-7,Brouwer-Visser J et al,doi: 10.1016/j.cytogfr.2015.01.002,,0001-06-01,,23620526,The prevalence of loss of imprinting of H19 and IGF2 at birth.,FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2018-08-01T20:13:00,27,8,3335-43,Rancourt RC et al,doi: 10.1096/fj.12-225284,,0001-08-01,
